ATS Abstracts

All sessions are held on August 5, 2020 at 9 a.m.

822 – Effectiveness of Bronchoscopic Lung Volume Reduction with Endobronchial Valves in Clinical Practice

P1038 – Role of Quantitative SPECT/CT in Pre-Procedural BLVR Planning in Patients with Advanced Emphysema

P75 – Redistribution of Perfusion from BLVR Targeted Lobe to Ipsilateral Non-Targeted Lobe Improves Oxygenation Independent of Lobar Volume Reduction

P566 – Serious Pneumothorax Events Following Bronchoscopic Lung Volume Reduction with Endobronchial Valves

P855 – Bronchoscopic Lung Volume Reduction with Endobronchial Zephyr Valves for Severe Emphysema in a Patient with a Pneumothorax

P463 – Effects of Bronchoscopic Lung Volume Reduction with Endobronchial Valves on Diaphragm Length

920 – Effects of Bronchoscopic Lung Volume Reduction on Heart-Lung Interaction in COPD Patients with Severe Pulmonary Emphysema

P1037 – Different Airway Structure Changes on Computed Tomography and Efficacy After Bronchoscopic Volume Reduction Using Two Different Valves Respectively for Advanced Chronic Obstructive Pulmonary Disease

P477 – Comparing Lung Perfusion Using Dual-Energy Computed Tomography and Single Photon Emission Computed Tomography in Patients with Severe Emphysema Prior to Bronchoscopic Lung Volume Reduction

P291 – Introducing Endoscopic Lung Volume Reduction with Endobronchial Valves for the Treatment of Severe Emphysema: Impact on Patient Volume and Use of Ancillary Services

P567 Physician Reimbursement vs Procedural Effort for Bronchoscopic Lung Volume Reduction with Endobronchial Valves in Clinical Practice

GLO-EN-607-v2

Privacy Preference Center